Bridgebio Pharma Inc. (bbio 2.25 02/01/29)
13F holders, Q1 2026 (March 31)7holders +2
4new positions
2sold out
$1.12avg. 13F price*
At the end of Q1 2026, 7 institutions reported holding Bridgebio Pharma Inc. (bbio 2.25 02/01/29) in their 13F filings, up 2 from Q4 2025. 4 opened new positions and 2 sold out. The largest holders were Ssi Investment Management LLC ($6.8M), BNP PARIBAS ASSET MANAGEMENT Holding S.A. ($2.8M) and Bank of New York Mellon Corp ($1.1M).
- Company
- Bridgebio Pharma Inc. (bbio 2.25 02/01/29)
- CUSIP
- 10806XAD4
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q4 2025 → Q1 2026
| Institutions | Total Value | |
|---|---|---|
| New Positions | 4 | $7.0M |
| Exits | 2 | $28.5M |
All 13F filers, Q4 2025 → Q1 2026: 7,049,000 shares bought and 25,343,000 shares sold, net −18,294,000 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 7 holders
| Ssi Investment Management LLC | 0.56% | New | 6,080,000 | $6.8M |
| BNP PARIBAS ASSET MANAGEMENT Holding S.A. | 0.00% | No change | 2,500,000 | $2.8M |
| Bank of New York Mellon Corp | 0.00% | Add +400.0% | 1,000,000 | $1.1M |
| Sei Investments Co. | 0.00% | Add +4.4% | 377,000 | $422K |
| Oppenheimer Asset Management Inc. | 0.00% | New | 105,000 | $117K |
| Stephens Inc. | 0.00% | New | 33,000 | $37K |
| &partners | 0.00% | New | 15,000 | $17K |
"% of holder's portfolio" is BRIDGEBIO PHARMA INC (BBIO 2.25 02/01/29)'s weight in each manager's 13F, not the share of Bridgebio Pharma Inc. (bbio 2.25 02/01/29) the manager owns.